Diagnostic utility of beta defensin 2 and LL-37 for the differenciation between complicated and non-complicated infectious pleural effusions

Carlos Antonio Amado Diago (Santander, Spain), Carlos Antonio Amado, Milagros Ruiz de Infante, María del Carmen Fariñas, María Teresa García-Unzueta, Pedro Muñoz, Francisca Santos

Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Session: Clinical issues in CAP: microbiological and radiological determinants
Session type: Thematic Poster Session
Number: 2594
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Carlos Antonio Amado Diago (Santander, Spain), Carlos Antonio Amado, Milagros Ruiz de Infante, María del Carmen Fariñas, María Teresa García-Unzueta, Pedro Muñoz, Francisca Santos. Diagnostic utility of beta defensin 2 and LL-37 for the differenciation between complicated and non-complicated infectious pleural effusions. Eur Respir J 2015; 46: Suppl. 59, 2594

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Human beta defensin-2 serum levels are lower in complicated infectious pleural effusions
Source: Annual Congress 2013 –Interesting research questions
Year: 2013


Expression of YKL-40 and MIP-1a proteins in exudates and transudates: Biomarkers for differential diagnosis of pleural effusions?
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Diagnostic values of inflammation biomarkers in pleural effusions (PE)
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015

Serum procalcitonin as a potential biomarker of surgery in parapneumonic pleural effusions
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Molecular assay for tuberculous pleural effusion
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013


Protein profiling of pleural fluid in guiding management of infectious parapneumonic effusion in children
Source: International Congress 2015 – Paediatric pulmonary infections
Year: 2015

Diagnostic value of pleural fluid adenosine deaminase level in patient with tuberculous pleurisy
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016


Association of biochemical determinants and fibrinous formation in malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


Pleural effusions after cardiac surgery: Etiology and outcomes
Source: International Congress 2016 – Open problems in thoracic surgery
Year: 2016


Risk factors associated to surgical treatment of parapneumonic effusion and empyema
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013


Infectious pleural effusions
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=204
Year: 2002

Predictive value of pro-inflammatory cytokine and pro-angiogenic factor in differentiating malignant from benign exudative effusion
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Risk of occult pleural infection in patients with malignant effusions
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013

Role of gene Xpert in diagnosis of tuberculous pleural effusion: Comparison with pleural biopsy
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014

Serum albumin and probability of pleural effusion in patients with community-acquired pneumonia
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013


Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016

Comparison of diagnostic utility of pleural fluid ADA and interferon-gamma release assay (IGRA) in differentiating tubercular and non-tubercular exudative pleural effusion
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015



Clinical and bacterial characteristics in Danish adults with pleural empyema
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014